Importantly, BRN2 may contribute to melanoma progression through regulation of MITF expression, repressing or activating the MITF promoter depending on cellular context (Goodall et al. 2008; Wellbrock et al. 2008). The gene discussed is POU3F2; the disease is melanoma.